750mg Levetiracetam Tablets IP

Name: 750mg Levetiracetam Tablets IP
Brand: UNIKA PHARMACEUTICALS PRIVATE LIMITED
Price: 110 INR
Availability: InStock

Price 110 INR/ Strip

Get a Price/Quote

MOQ : 50 Strips

750mg Levetiracetam Tablets IP Specification

Dosage Guidelines
As directed by physician

Molecular Formula
C8H14N2O2

Appearance
White to off-white tablet

Purity
Pharmaceutical grade

Assay
NLT 98.0%

CAS No
102767-28-2

Pacakaging (Quantity Per Box)
10 tablets

Suitable For
Adults

Melting Point
~115-116C

Solubility
Freely soluble in water

Physical Form
Tablet

HS Code
300490

Type
Antiepileptic Drug

Ingredients
Levetiracetam 750mg

Feature
Extended Release

Shelf Life
24 months

Storage Instructions
Store in cool, dry place

Tablet Shape
Oval

Usage
Generalized Seizure

Pack Size
10 tablets

Brand Name
Levectra 750

Blister Pack
Yes

Packaging Type
Strip

Prescription
Prescription

Route
Oral

Manufacturing Standard
IP standard

Strength
750 mg

Release Type
Extended

750mg Levetiracetam Tablets IP Trade Information

Minimum Order Quantity
50 Strips

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Strips Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About 750mg Levetiracetam Tablets IP

Levectra 750 offers masterful control for generalized seizures, formulated as 750mg Levetiracetam Tablets IP. Highlighted by its extended release feature, this unmatchable antiepileptic drug delivers consistent efficacy for adult patients. Select Levectra 750 for best-in-class quality, meeting strict IP standards with pharmaceutical purity (NLT 98.0%). Each oval, white-to-off white tablet is packed in a secure blister strip, ensuring medication integrity. Best price guaranteed, Levectra 750 is suitable for prescription use and manufactured for reliable performance. Store in a cool, dry place for optimal shelf life of 24 months.

Application & Usage: Precision in Seizure Management

Levectra 750 tablets are applied as a robust solution for adults facing generalized seizures. Used as a masterful antiepileptic therapy, this extended release tablet ensures sustained medicinal impact over time. Selectively prescribed for routine seizure prevention, the oral route and easy-to-swallow oval shape add to the convenience. The usage guidelines recommend administration strictly as directed by a physician, highlighting its safety profile and controlled, effective seizure management.

Packaging & Supply: Secure and Reliable Handover

Each blister pack contains 10 tablets, assuring both hygienic handling and accurate dosing. Shipped goods are carefully packed in durable strips for optimal protection during transit. The asking price reflects best value for pharmaceutical grade quality. We maintain a steady supply ability for bulk orders and ensure on-time handover through major FOB ports in India. These packaging details are carefully designed to meet regulatory, efficiency, and customer satisfaction standards throughout the supply chain.

FAQ's of 750mg Levetiracetam Tablets IP:

Q: How should 750mg Levetiracetam Tablets IP be stored?

A: Store Levectra 750 tablets in a cool, dry place to maintain their efficacy and preserve product integrity over the full 24-month shelf life.

Q: What is the application surface and primary usage of Levectra 750?

A: Levectra 750 is primarily used for adults experiencing generalized seizures, prescribed strictly under a physician's direction for safe, controlled antiepileptic therapy.

Q: When is the recommended time to take this medication?

A: Take Levectra 750 as directed by your physician, typically at the same time each day for consistent therapeutic coverage, unless otherwise advised.

Q: Where are the tablets manufactured and supplied from?

A: Levectra 750 tablets are manufactured in India, adhering to IP standards, and supplied globally through secure and regulated distribution channels.

Q: What is the benefit of choosing the extended release feature?

A: The extended release formulation provides steady medication levels, offering unmatchable seizure control and reducing dosing frequency for improved patient compliance.